Merck unveils bio-based HPLC solvents slashing CO2 emissions by up to 29%
Solvents made from renewable feedstocks help reduce reliance on fossil-fuel-based materials
Solvents made from renewable feedstocks help reduce reliance on fossil-fuel-based materials
To boost compostable packaging, resin innovation, and supply chain speed
CDSCO-approved therapy enters India’s fast-growing post-patent GLP-1 market with fully integrated API, formulation and pen manufacturing
CDSCO-cleared BSM-5700 series targets ICU, NICU, ER, OR and digital health integration under ABDM
Effective recovery at home begins with well-defined care plans that outline treatment protocols, recovery milestones, and monitoring requirements tailored to individual patient needs
A brand from Opella will be part of the official NASA astronaut formulary
36 districts to get advanced ALS, BLS and neonatal ambulances under MEMS 108
Surgeon Yuvaraja operates on a 55-year-old patient at Medical City Hospital Muscat
In just the last few days, companies including Lupin, Biocon, Alembic Pharmaceuticals and Aurobindo Pharma have announced approvals for 5 mg and 10 mg tablets, all bioequivalent to Farxiga
Subscribe To Our Newsletter & Stay Updated